Chemed Price to Free Cash Flow Ratio 2010-2024 | CHE

Historical price to free cash flow ratio values for Chemed (CHE) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Chemed Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2025-01-17 554.73 141.03
2024-09-30 600.43 $3.93 152.65
2024-06-30 541.62 $6.41 84.52
2023-12-31 583.32 $18.03 32.35
2023-09-30 518.08 $23.81 21.76
2023-06-30 539.56 $27.38 19.71
2023-03-31 535.28 $22.39 23.91
2022-12-31 507.72 $22.51 22.56
2024-03-31 640.79 $16.20 39.55
2022-09-30 433.91 $14.56 29.81
2022-06-30 466.18 $18.45 25.27
2022-03-31 502.72 $16.13 31.16
2021-12-31 524.65 $15.74 33.34
2021-09-30 460.93 $17.04 27.05
2021-06-30 469.86 $17.50 26.85
2021-03-31 455.01 $27.61 16.48
2020-12-31 526.63 $26.35 19.98
2020-09-30 474.63 $25.04 18.96
2020-06-30 445.40 $25.12 17.73
2020-03-31 427.46 $15.61 27.39
2019-12-31 433.11 $15.02 28.84
2019-09-30 411.40 $14.33 28.72
2019-06-30 355.25 $13.06 27.20
2019-03-31 314.82 $14.44 21.80
2018-12-31 278.38 $13.94 19.97
2018-09-30 313.76 $9.00 34.88
2018-06-30 315.65 $7.14 44.23
2018-03-31 267.41 $3.28 81.50
2017-12-31 237.91 $-0.09 0.00
2017-09-30 197.56 $5.26 37.54
2017-06-30 199.70 $4.76 41.98
2016-12-31 156.19 $5.70 27.42
2016-09-30 137.10 $9.71 14.12
2016-06-30 132.23 $10.49 12.61
2016-03-31 131.16 $8.91 14.73
2015-12-31 144.79 $11.85 12.22
2017-03-31 178.14 $8.32 21.42
2015-09-30 128.80 $7.40 17.40
2015-06-30 126.30 $5.22 24.20
2015-03-31 114.83 $5.05 22.74
2014-12-31 101.43 $3.74 27.13
2014-09-30 98.57 $1.32 74.87
2014-06-30 89.58 $4.15 21.57
2014-03-31 85.31 $5.30 16.09
2013-12-31 72.90 $6.54 11.15
2013-09-30 67.85 $8.69 7.81
2013-06-30 68.54 $6.94 9.87
2013-03-31 75.49 $5.22 14.46
2012-12-31 64.59 $4.99 12.94
2012-09-30 65.06 $5.52 11.79
2012-06-30 56.59 $7.11 7.96
2012-03-31 58.52 $4.86 12.04
2011-12-31 47.69 $6.91 6.90
2011-09-30 51.04 $4.94 10.33
2011-06-30 60.67 $3.93 15.43
2011-03-31 61.55 $4.49 13.71
2010-12-31 58.56 $2.62 22.34
2010-09-30 52.41 $4.85 10.82
2010-06-30 50.13 $4.88 10.27
2010-03-31 49.79 $5.21 9.56
2009-12-31 43.82 $6.13 7.15
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.349B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.877B 0.00
Quest Diagnostics (DGX) United States $16.876B 17.10
DaVita (DVA) United States $13.632B 17.63
Encompass Health (EHC) United States $9.545B 22.50
Elanco Animal Health (ELAN) United States $5.942B 14.14
Option Care Health (OPCH) United States $4.962B 23.52
RadNet (RDNT) United States $4.431B 98.13
LifeStance Health (LFST) United States $3.057B 0.00
Amedisys (AMED) United States $3.010B 21.42
Addus HomeCare (ADUS) United States $2.427B 28.48
Astrana Health (ASTH) United States $1.978B 27.05
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.943B 38.14
Aveanna Healthcare Holdings (AVAH) United States $0.899B 0.00
Atai Life Sciences (ATAI) Germany $0.245B 0.00
Bioqual (BIOQ) United States $0.058B 0.00
Daxor (DXR) United States $0.041B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00